Individualised medicine and health care system. Summary

There is already a medical need for increasing patient involvement in health care, and this is likely to increase in the future. Visions of technology suggest that an "individualised health care" could emerge from the combination of this trend with findings from the life sciences in about...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hüsing, Bärbel, Hartig, Juliane, Bührlen, Bernhard, Reiß, Thomas, Gaisser, Sibylle
Format: Report
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Hüsing, Bärbel
Hartig, Juliane
Bührlen, Bernhard
Reiß, Thomas
Gaisser, Sibylle
description There is already a medical need for increasing patient involvement in health care, and this is likely to increase in the future. Visions of technology suggest that an "individualised health care" could emerge from the combination of this trend with findings from the life sciences in about twenty years: Medical services that can be more specifically adapted to the individual than in the past are seen as having the potential to achieve more ambitious quality and cost targets in health care. Such individualised medicine could permeate all stages of service provision - from prevention and (early) diagnosis to therapy and follow-up monitoring. It is based on such diverse scientific and technological developments as genome analyses, nanomedicine, autologous cell therapies, molecular imaging, nutrigenomics or the determination of patient-specific protein expression patterns. Subject and objective of the project The Committee on Education, Research and Technology Assessment commissioned a report on the future of this topic, which is still predominantly in the research and development stage. Already in the early phase of the research and health policy discussion on the future option, the aim was to analyse > which lines of development in the life sciences can contribute to individualised medicine, > how the current state of science and technology and possible future developments are to be assessed, > what implications arise for technology development and the embedding of these technologies in the future health care system if they are to contribute to individualised medicine, and > what implications could arise from individualised medicine for medical care, for companies and health insurance.
doi_str_mv 10.5445/ir/1000137968
format Report
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_5445_ir_1000137968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_5445_ir_1000137968</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_5445_ir_10001379683</originalsourceid><addsrcrecordid>eNqVzbEKwjAQgOEsDqKO7vcCbRPaWp1F0Vn3cPSu9CAJkqRC314KgrPTv3zwK7U3umybpq0kVkZrberudDiuVXcPJG-hCZ0kJvBM0ktgwEAwMro8Qo-RIc0psy_hMXmPcd6q1YAu8e7bjSqul-f5VhBm7CWzfUVZoDXaLmMr0f7G9b_-A_32Oj8</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Individualised medicine and health care system. Summary</title><source>DataCite</source><creator>Hüsing, Bärbel ; Hartig, Juliane ; Bührlen, Bernhard ; Reiß, Thomas ; Gaisser, Sibylle</creator><creatorcontrib>Hüsing, Bärbel ; Hartig, Juliane ; Bührlen, Bernhard ; Reiß, Thomas ; Gaisser, Sibylle</creatorcontrib><description>There is already a medical need for increasing patient involvement in health care, and this is likely to increase in the future. Visions of technology suggest that an "individualised health care" could emerge from the combination of this trend with findings from the life sciences in about twenty years: Medical services that can be more specifically adapted to the individual than in the past are seen as having the potential to achieve more ambitious quality and cost targets in health care. Such individualised medicine could permeate all stages of service provision - from prevention and (early) diagnosis to therapy and follow-up monitoring. It is based on such diverse scientific and technological developments as genome analyses, nanomedicine, autologous cell therapies, molecular imaging, nutrigenomics or the determination of patient-specific protein expression patterns. Subject and objective of the project The Committee on Education, Research and Technology Assessment commissioned a report on the future of this topic, which is still predominantly in the research and development stage. Already in the early phase of the research and health policy discussion on the future option, the aim was to analyse &gt; which lines of development in the life sciences can contribute to individualised medicine, &gt; how the current state of science and technology and possible future developments are to be assessed, &gt; what implications arise for technology development and the embedding of these technologies in the future health care system if they are to contribute to individualised medicine, and &gt; what implications could arise from individualised medicine for medical care, for companies and health insurance.</description><identifier>DOI: 10.5445/ir/1000137968</identifier><language>eng</language><publisher>Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB)</publisher><subject>Diabetes ; Diagnosis ; Health care ; Health economy ; Health policy ; Medical care ; Medical research ; Medicines ; Private health insurance ; Research policy ; Statutory health insurance ; Study ; Technology assessment ; Therapy</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1887,4475</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.5445/ir/1000137968$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hüsing, Bärbel</creatorcontrib><creatorcontrib>Hartig, Juliane</creatorcontrib><creatorcontrib>Bührlen, Bernhard</creatorcontrib><creatorcontrib>Reiß, Thomas</creatorcontrib><creatorcontrib>Gaisser, Sibylle</creatorcontrib><title>Individualised medicine and health care system. Summary</title><description>There is already a medical need for increasing patient involvement in health care, and this is likely to increase in the future. Visions of technology suggest that an "individualised health care" could emerge from the combination of this trend with findings from the life sciences in about twenty years: Medical services that can be more specifically adapted to the individual than in the past are seen as having the potential to achieve more ambitious quality and cost targets in health care. Such individualised medicine could permeate all stages of service provision - from prevention and (early) diagnosis to therapy and follow-up monitoring. It is based on such diverse scientific and technological developments as genome analyses, nanomedicine, autologous cell therapies, molecular imaging, nutrigenomics or the determination of patient-specific protein expression patterns. Subject and objective of the project The Committee on Education, Research and Technology Assessment commissioned a report on the future of this topic, which is still predominantly in the research and development stage. Already in the early phase of the research and health policy discussion on the future option, the aim was to analyse &gt; which lines of development in the life sciences can contribute to individualised medicine, &gt; how the current state of science and technology and possible future developments are to be assessed, &gt; what implications arise for technology development and the embedding of these technologies in the future health care system if they are to contribute to individualised medicine, and &gt; what implications could arise from individualised medicine for medical care, for companies and health insurance.</description><subject>Diabetes</subject><subject>Diagnosis</subject><subject>Health care</subject><subject>Health economy</subject><subject>Health policy</subject><subject>Medical care</subject><subject>Medical research</subject><subject>Medicines</subject><subject>Private health insurance</subject><subject>Research policy</subject><subject>Statutory health insurance</subject><subject>Study</subject><subject>Technology assessment</subject><subject>Therapy</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2008</creationdate><recordtype>report</recordtype><sourceid>PQ8</sourceid><recordid>eNqVzbEKwjAQgOEsDqKO7vcCbRPaWp1F0Vn3cPSu9CAJkqRC314KgrPTv3zwK7U3umybpq0kVkZrberudDiuVXcPJG-hCZ0kJvBM0ktgwEAwMro8Qo-RIc0psy_hMXmPcd6q1YAu8e7bjSqul-f5VhBm7CWzfUVZoDXaLmMr0f7G9b_-A_32Oj8</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Hüsing, Bärbel</creator><creator>Hartig, Juliane</creator><creator>Bührlen, Bernhard</creator><creator>Reiß, Thomas</creator><creator>Gaisser, Sibylle</creator><general>Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB)</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>2008</creationdate><title>Individualised medicine and health care system. Summary</title><author>Hüsing, Bärbel ; Hartig, Juliane ; Bührlen, Bernhard ; Reiß, Thomas ; Gaisser, Sibylle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_5445_ir_10001379683</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Diabetes</topic><topic>Diagnosis</topic><topic>Health care</topic><topic>Health economy</topic><topic>Health policy</topic><topic>Medical care</topic><topic>Medical research</topic><topic>Medicines</topic><topic>Private health insurance</topic><topic>Research policy</topic><topic>Statutory health insurance</topic><topic>Study</topic><topic>Technology assessment</topic><topic>Therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Hüsing, Bärbel</creatorcontrib><creatorcontrib>Hartig, Juliane</creatorcontrib><creatorcontrib>Bührlen, Bernhard</creatorcontrib><creatorcontrib>Reiß, Thomas</creatorcontrib><creatorcontrib>Gaisser, Sibylle</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hüsing, Bärbel</au><au>Hartig, Juliane</au><au>Bührlen, Bernhard</au><au>Reiß, Thomas</au><au>Gaisser, Sibylle</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>Individualised medicine and health care system. Summary</btitle><date>2008</date><risdate>2008</risdate><abstract>There is already a medical need for increasing patient involvement in health care, and this is likely to increase in the future. Visions of technology suggest that an "individualised health care" could emerge from the combination of this trend with findings from the life sciences in about twenty years: Medical services that can be more specifically adapted to the individual than in the past are seen as having the potential to achieve more ambitious quality and cost targets in health care. Such individualised medicine could permeate all stages of service provision - from prevention and (early) diagnosis to therapy and follow-up monitoring. It is based on such diverse scientific and technological developments as genome analyses, nanomedicine, autologous cell therapies, molecular imaging, nutrigenomics or the determination of patient-specific protein expression patterns. Subject and objective of the project The Committee on Education, Research and Technology Assessment commissioned a report on the future of this topic, which is still predominantly in the research and development stage. Already in the early phase of the research and health policy discussion on the future option, the aim was to analyse &gt; which lines of development in the life sciences can contribute to individualised medicine, &gt; how the current state of science and technology and possible future developments are to be assessed, &gt; what implications arise for technology development and the embedding of these technologies in the future health care system if they are to contribute to individualised medicine, and &gt; what implications could arise from individualised medicine for medical care, for companies and health insurance.</abstract><pub>Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB)</pub><doi>10.5445/ir/1000137968</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.5445/ir/1000137968
ispartof
issn
language eng
recordid cdi_datacite_primary_10_5445_ir_1000137968
source DataCite
subjects Diabetes
Diagnosis
Health care
Health economy
Health policy
Medical care
Medical research
Medicines
Private health insurance
Research policy
Statutory health insurance
Study
Technology assessment
Therapy
title Individualised medicine and health care system. Summary
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T17%3A03%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=Individualised%20medicine%20and%20health%20care%20system.%20Summary&rft.au=H%C3%BCsing,%20B%C3%A4rbel&rft.date=2008&rft_id=info:doi/10.5445/ir/1000137968&rft_dat=%3Cdatacite_PQ8%3E10_5445_ir_1000137968%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true